Particle.news
Download on the App Store

FDA Expands Review of Possible COVID Vaccine-Linked Deaths to Multiple Age Groups

The agency faces pressure to disclose case-level evidence after an internal memo cited unverified pediatric deaths, prompting proposals for tougher vaccine standards.

Overview

  • HHS confirmed the FDA is conducting a broad safety review across age groups after initial attention to pediatric reports.
  • The FDA has not released case-level data or peer-reviewed analyses underpinning the claim that about 10 children died after vaccination.
  • Three senior House Energy and Commerce Democrats requested deidentified case files, methods and documentation by December 19.
  • Twelve former FDA commissioners warned that proposed shifts to require larger randomized trials and other changes could undermine evidence-based vaccine policy.
  • Pfizer and Moderna reiterated that extensive monitoring has revealed no new undisclosed safety issues, and experts note VAERS reports alone do not establish causation.